Feature

GOODBYE FSA

CASSH

GOODBYE FSA

SPECIAL REPORT

Neptune UK Mid Cap fund manager Mark Martin looks at the prospects for companies in the out of favour pharmaceutical industry.

Brewin Dolphin's John Newlands explains why investors should stick with veteran managers even when new and exciting opportunities enter the market.

Following the announcement of Robert Parker's latest wine scores, Scott Assemakis, managing director and founder of European Fine Wines, analyses the state of the asset class.

Peter McKellar, coordinating partner and CIO of SL Capital Partners and manager of the Standard Life European Private Equity trust, on the prospects for this unloved sector.

AIM

ONE TO WATCH